| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 09/06/2006 | EP1243595B1 Bh4-fused polypeptides |
| 09/06/2006 | EP1214350B1 Peptides for combating the autoantibodies that are responsible for dilatative cardiomyopathy (dcm) |
| 09/06/2006 | EP1135374B1 Benzimidazole compounds that are vitronectin receptor antagonists |
| 09/06/2006 | EP0832232B9 Kunitz type plasma kallikrein inhibitors |
| 09/06/2006 | CN1829694A Quinoline derivates and their use in therapy |
| 09/06/2006 | CN1829511A Use of angiotensin II receptor antagonists, especially telmisartan, in order to increase insulin sensitivity |
| 09/06/2006 | CN1829506A Novel coumarin-amide derivatives and its preparation, its drug composition and use |
| 09/06/2006 | CN1829505A The use of fumaric acid derivatives for treating cardiac insufficiency, and asthma |
| 09/06/2006 | CN1827638A Vancomycin and nor-vancomycin derivatives and their preparation process and use |
| 09/06/2006 | CN1827635A Glycopeptide compositions |
| 09/06/2006 | CN1827618A Isoquinoline derivatives and their preparation process and application |
| 09/06/2006 | CN1827602A Crystalline form gamma of the chlorhydrate of ivabradine, process for its preparation and phamaceutical composition containing it |
| 09/06/2006 | CN1827601A Crystalline form gamma-d of the chlorohydrate of ivabradine, process for its preparation and pharmaceutical compositions containing it |
| 09/06/2006 | CN1827600A Crystalline form beta of the chlorhydrate of ivabradine, process for its preparation and pharamcetuical composition containing it |
| 09/06/2006 | CN1827599A Crystalline form beta-d of the chlorohydrate of ivabradine, process for its preparation and pharmaceutical compositions containing it |
| 09/06/2006 | CN1827169A Composite preparation containing nitrate esters medicine and HMG-CoA reductase inhibitor |
| 09/06/2006 | CN1827155A Consciousness-restoring granule with pearl |
| 09/06/2006 | CN1827138A Chinese medicine composition prescription for treating cardiovascular and cerebrovascular diseases and preparation technique thereof |
| 09/06/2006 | CN1827130A Formulation prepared from effective parts of red sage root and moutan bark, its compound preparation method and medical application |
| 09/06/2006 | CN1827125A Compound orally disintegrating tablet of red sage root, its preparation method and quality control method |
| 09/06/2006 | CN1827121A Preparation of safflower and its extract and their medical application in promoting tissue blood vessel regeneration |
| 09/06/2006 | CN1827116A First-class new medicine cyclovirobuxine D series for treating cardiovascular and cerebrovascular disease and method for preparing the same |
| 09/06/2006 | CN1827114A Pharmaceutical composition using efonidipine as active ingredient, its preparation method and use |
| 09/06/2006 | CN1827112A Dispersion tablet for treating cardiovascular diseases and its preparation method |
| 09/06/2006 | CN1827111A Pharmaceutical composition using benazepril hydrochloride amlodipine besylate as active ingredients, its preparation method and use |
| 09/06/2006 | CN1827110A Pharmaceutical composition using hydrochlorothiazide and benazepril hydrochloride as active ingredients, its preparation method and use |
| 09/06/2006 | CN1827109A Lyophilized injection powder using Lanluodier and its salt as active ingredients and preparing technique therefor |
| 09/06/2006 | CN1827104A Pharmaceutical compositions of levo-amlodipine and atorvastatin |
| 09/06/2006 | CN1827103A Pharmaceutical composition containing eprosartan, its preparation method and use |
| 09/06/2006 | CN1827099A Intravenous administered injection of ginkgolide B, its preparation method and application |
| 09/06/2006 | CN1827093A Taurine injection and method for preparing the same |
| 09/06/2006 | CN1826974A Health seasoning |
| 09/06/2006 | CN1826951A Health-caring vermicelli for heart disease patient |
| 09/06/2006 | CN1826917A Health drink with milk and snow lotus live body and preparation method |
| 09/06/2006 | CN1273466C Quinoline derivatives and quinazoline derivatives having azolyl group |
| 09/06/2006 | CN1273465C Method for preparing pyrimidinone compound and pharmaceutically acceptable salts thereof |
| 09/06/2006 | CN1273463C (1-phenacy-3-phenyl-3-piperidylethyl)piperidine derivatives, method for production thereof and pharmaceutical compositions containing the same |
| 09/06/2006 | CN1273456C Thiazole or oxazole derivatives |
| 09/06/2006 | CN1273450C 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6ligands |
| 09/06/2006 | CN1273444C Dipeptide nitriles |
| 09/06/2006 | CN1273195C Carbonized pollen and its application in preparation of cancer-treating medicine |
| 09/06/2006 | CN1273171C Medicine for treating hypertension and apoplexy caused thereby |
| 09/06/2006 | CN1273162C Medicine for treating pile and fistula |
| 09/06/2006 | CN1273160C Medicine for fumigating piles |
| 09/06/2006 | CN1273148C Hypertension-treating sage whole plant products and preparation |
| 09/06/2006 | CN1273141C Oral pharmaceutical products containing 17beta-estradiol-3-lower alkanoate and preparation method thereof |
| 09/06/2006 | CN1273135C Pharmaceutical composition of N-methyl-D-aspartate receptor agonist |
| 09/06/2006 | CN1273129C Therapeutic compositions (II) |
| 09/06/2006 | CN1273125C Application of BAPTA derivative in the preparing process of clinical medicine |
| 09/06/2006 | CN1273119C Anti-atherosclerosis composition containing carotenoilds and method for inhibiting LDL oxidation |
| 09/06/2006 | CN1273116C Orally disintegrating tablet of gingko leaf and its preparation process |
| 09/06/2006 | CN1273115C Quick-acting and heart-resurrecting oral disintegrating tablet and its preparation process |
| 09/06/2006 | CN1273107C Preparation process of a Chinese medicinal drop pills for preventing or treating coronary disease |
| 09/06/2006 | CN1273106C Therapeutic patch |
| 09/05/2006 | US7102013 Treating under hydrolyzing conditions a hydantoin compound to form an alpha-amino acid derivative |
| 09/05/2006 | US7102009 For treating cancer and angiogenesis-related disorders |
| 09/05/2006 | US7102007 Dihydroindole and tetrahydroquinoline derivatives |
| 09/05/2006 | US7102000 Heterocyclic amide derivatives for the treatment of diabetes and other diseases |
| 09/05/2006 | US7101977 Targeted killing of a cell utilizing a chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor |
| 09/05/2006 | US7101912 when co-administered with levodopa in the colon of a patient is taken up at a much higher bioavailability than levodopa alone; treating Parkinson's disease or hypertension; dosage forms; sustained release; oral administration |
| 09/05/2006 | US7101911 Bis(substituted propynyl)-substituted benzenes, pyridines, pyrimidines, pyrazines, pyridines, furans and pyrroles; e.g., 3,5-bis-(3-(4-aminomethylbenzylaminocarbonyloxy)prop-1-ynyl)--1 -hydroxymethylbenzene |
| 09/05/2006 | US7101910 For therapy of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis |
| 09/05/2006 | US7101905 Pharmaceutically active compounds and methods of use |
| 09/05/2006 | US7101901 Treating Parkinson, Huntington's chorea, cerebral circulatory disorders, ischemia, cerebral ischemia, apoplexy, cerebral apoplexy, senile dementia, and Alzheimer's disease |
| 09/05/2006 | US7101899 N-[4-[2-Ethyl-4-(3-methylphenyl)-1,3-thiazol-5-yl]-2-pyridyl]benzamide; adenosine A3 receptor antagonistic activity |
| 09/05/2006 | US7101884 Tyrosine kinase inhibitors |
| 09/05/2006 | US7101882 Morpholin-acetamide derivatives for the treatment of inflammatory diseases |
| 09/05/2006 | US7101877 Trans-[2-(4-Morpholinyl)-1-(2-Naphthenethoxy)]Cyclohexane Monohydrochloride; selectively inhibiting cardiac early repolarising currents and cardiac sodium currents |
| 09/05/2006 | US7101868 A 2-(((4-fluorophenyl)methyl)amino)-3-pyridinecarboxamide derivatives for treating cancer, angiogenesis, tumor |
| 09/05/2006 | US7101864 N-(2-acetamidoethyl)phosphonoformamide; inhibiting effect on zinc-containing proteinases, inhibiting cancer cells |
| 09/05/2006 | US7101860 Composition and method for inhibiting platelet aggregation |
| 09/05/2006 | US7101856 Thiophene glycoside derivatives, processes for the preparation, medicaments comprising these compounds, and the use thereof |
| 09/05/2006 | US7101851 IgE receptor antagonists |
| 09/05/2006 | US7101849 ωconotoxin peptides |
| 09/05/2006 | US7101843 Amino acid sequence of His-Val-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Glu-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Ile-Lys-Gly-Arg-Gly-OH; obesity, stroke, myocardial infarction, irritable bowel syndrome, non-insulin dependent diabetes |
| 09/05/2006 | US7101838 Method to prevent accelerated atherosclerosis using (sRAGE) soluble receptor for advanced glycation endproducts |
| 09/05/2006 | US7101577 Extract of plant Dendrobii caulis and preparing process thereof |
| 09/05/2006 | US7101574 Pharmaceutical composition containing fenofibrate and the preparation method |
| 09/05/2006 | US7101559 Immunomodulatory protein and useful embodiments thereof |
| 09/05/2006 | US7101550 Agents for modulating PD-1, B7-4, and the interaction between B7-4 and PD-1 in order to modulate a costimulatory or an inhibitory signal in a immune cell resulting in modulation of the immune response |
| 09/01/2006 | CA2499047A1 Process for producing atorvastatin hemicalcium |
| 08/31/2006 | WO2006091800A2 Novel pyridine derivatives as potassium ion channel openers |
| 08/31/2006 | WO2006091034A1 A composition for treating stroke comprising carboxylate derivative |
| 08/31/2006 | WO2006090931A1 Novel concomitant use of sulfonamide compound with anti-cancer agent |
| 08/31/2006 | WO2006090928A1 Novel use of sulfonamide compound in combination with angiogenesis inhibitor |
| 08/31/2006 | WO2006090882A1 Method for amplification of endothelial progenitor cell in vitro |
| 08/31/2006 | WO2006090850A1 Benzamide compound |
| 08/31/2006 | WO2006090817A1 Indole compound and use thereof |
| 08/31/2006 | WO2006090768A1 Process for production of optically active ppar-activating compound and intermediate of the same |
| 08/31/2006 | WO2006090699A1 Preventive or therapeutic agent for cardiac dysfunction or myocardial damage caused by ischemia or ischemia-reperfusion |
| 08/31/2006 | WO2006090698A1 Kinase inhibitor and use thereof |
| 08/31/2006 | WO2006090697A1 Therapeutic agent for disease with apoptotic degeneration in eye tissue cell containing pedf and fgf2 |
| 08/31/2006 | WO2006090616A1 Fat cell differentiation regulator |
| 08/31/2006 | WO2006090557A1 Preventive or therapeutic agent for stroke or sequelae of stroke comprising as main component salvianolic acid b or the like |
| 08/31/2006 | WO2006090555A1 Akt ACTIVATING AGENT |
| 08/31/2006 | WO2006090224A1 Benzisoxazole derivatives |
| 08/31/2006 | WO2006090150A1 Pharmaceutical composition comprising amorphous rosiglitazone |
| 08/31/2006 | WO2006089871A2 Diphenylurea derivatives useful as erg channel openers for the treatment of cardiac arrhythmias |
| 08/31/2006 | WO2006089787A1 Amorphous lercanidipine hydrochloride |
| 08/31/2006 | WO2006089586A1 Use of a compound with clusterin activity for the treatment of diseases associated with the deposition of abnormal proteins |